β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study
Abstract Background Long term β-blocker therapy after myocardial infarction (MI) reduces mortality and recurrent MI but evidence for this treatment predates contemporary acute coronary care. β-blocker treatment is a key quality of care indicator in the Swedish national quality register for acute cor...
Main Authors: | Tora Hagsund, Sven-Erik Olsson, J. Gustav Smith, Bjarne Madsen Hardig, Henrik Wagner |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12872-020-01441-0 |
Similar Items
-
Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?
by: Roberto F.E. Pedretti
Published: (2018-06-01) -
Beta adrenergic blockade in myocardial infarction
by: Yusuf, Salim
Published: (1980) -
Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction
by: Liyew Desta, et al.
Published: (2021-02-01) -
Long-Term Effect of Non-Selective Beta-Blockers in Patients With Rheumatoid Arthritis After Myocardial Infarction—A Nationwide Cohort Study
by: Sheng-Fu Liu, et al.
Published: (2021-09-01) -
THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2017-12-01)